Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Irene Gagliardi"'
Autor:
Irene Gagliardi, Sabrina Chiloiro, Maria Vallillo, Marta Bondanelli, Stefano Volpato, Antonella Giampietro, Antonio Bianchi, Laura De Marinis, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Publikováno v:
BMC Geriatrics, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Improvement in acromegaly management increased disease survival and prevalence. Evidence regarding acromegaly in older adults are sparse. We aim to explore acromegaly impact on aging process quality. Methods Multicenter case-contr
Externí odkaz:
https://doaj.org/article/ed99e9338fc9474d99e8cd4c8aed712e
Autor:
Ludovica Aliberti, Irene Gagliardi, Roberta Rizzo, Daria Bortolotti, Giovanna Schiuma, Paola Franceschetti, Roberta Gafà, Luca Borgatti, Michele A. Cavallo, Maria C. Zatelli, Maria R. Ambrosio
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
A 50-year-old man was admitted to our hospital for vomit, nausea, diplopia, and headache resistant to analgesic drugs. Symptoms started the day after his third COVID-19 mRNA vaccine (Moderna) whereas SARS-CoV-2 nasal swab was negative. Pituitary MRI
Externí odkaz:
https://doaj.org/article/350ba050b057474c809b54440cd22528
Autor:
Irene Gagliardi, Mario Tarquini, Maria Rosaria Ambrosio, Elisa Giannetta, Patricia Borges de Souza, Roberta Gafà, Aldo Carnevale, Paola Franceschetti, Maria Chiara Zatelli
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2021)
Survival prognostic markers are extremely needed to better define therapeutic strategies in patients with bronchial carcinoids (BC). We aim to verify the applicability of the NEP-Score in a homogeneous BC cohort and identify a derivative prognostic m
Externí odkaz:
https://doaj.org/article/a48f1b7fb1d449499cdc88660347ec9d
Publikováno v:
L'Endocrinologo. 24:125-128
SommarioL’incidenza delle neoplasie neuroendocrine (NEN) sta incrementando significativamente, mentre la sopravvivenza dei pazienti non migliora con la stessa velocità, a causa di diagnosi tardive e della mancanza di criteri prognostici consolidat
Autor:
Irene Gagliardi, Ludovica Aliberti, Margherita Medici, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Publikováno v:
L'Endocrinologo. 24:29-33
SommarioLa differente modulazione dell’asse GH/IGF-1 da parte degli steroidi sessuali suggerisce una diversa presentazione clinica dell’acromegalia nei due sessi. Tra le donne acromegaliche è stato registrato un maggiore ritardo diagnostico, un
Autor:
Aldo, Carnevale, Fabio, Pellegrino, Beatrice, Bravi, Maria Rita, Gamberini, Irene, Gagliardi, Roberto, Reverberi, Maria Chiara, Zatelli, Melchiore, Giganti, Maria Rosaria, Ambrosio
Publikováno v:
European Journal of Haematology. 109:648-655
Dual-energy X-ray absorptiometry (DXA) remains the cornerstone for osteoporosis evaluation in Thalassemia major. However, several drawbacks have been observed in this unique setting. We sought to determine the correlation between quantitative CT (QCT
Autor:
Luca Urso, Alberto Nieri, Ilaria Rambaldi, Angelo Castello, Licia Uccelli, Corrado Cittanti, Stefano Panareo, Irene Gagliardi, Maria Rosaria Ambrosio, Maria Chiara Zatelli, Mirco Bartolomei
Publikováno v:
Endocrine. 78:255-261
In the last 10 years, several literature reports supported radioligand therapy (RLT) in neoadjuvant settings for pancreatic neuroendocrine tumors (PanNETs). Indeed, primary tumor shrinkage has been frequently reported following RLT in unresectable or
Autor:
Irene Gagliardi, de Souza Patricia Borges, Lucrezia Rossi, Ambrosio Maria Rosaria, Zatelli Maria Chiara
Publikováno v:
Endocrine Abstracts.
Autor:
Irene Gagliardi, Mariella Celico, Maria Rita Gamberini, Margherita Pontrelli, Monica Fortini, Aldo Carnevale, Nicola Napoli, Maria Chiara Zatelli, Maria Rosaria Ambrosio
Publikováno v:
Calcified Tissue International. 111:56-65
Osteoporosis represents a relevant cause of morbidity in adult Thalassemia Major (TM) population. Antiresorptive drugs such as bisphosphonates were demonstrated effective in preventing bone loss. Teriparatide (TP) is an anabolic agent approved for os
Autor:
Giorgio Grani, Michele Gentili, Federico Siciliano, Domenico Albano, Valentina Zilioli, Silvia Morelli, Efisio Puxeddu, Maria Chiara Zatelli, Irene Gagliardi, Alessandro Piovesan, Alice Nervo, Umberto Crocetti, Michela Massa, Maria Teresa Samà, Chiara Mele, Maurilio Deandrea, Laura Fugazzola, Barbara Puligheddu, Alessandro Antonelli, Ruth Rossetto, Annamaria D’Amore, Graziano Ceresini, Roberto Castello, Erica Solaroli, Marco Centanni, Salvatore Monti, Flavia Magri, Rocco Bruno, Clotilde Sparano, Luciano Pezzullo, Anna Crescenzi, Caterina Mian, Dario Tumino, Andrea Repaci, Maria Grazia Castagna, Vincenzo Triggiani, Tommaso Porcelli, Domenico Meringolo, Laura Locati, Giovanna Spiazzi, Giulia Di Dalmazi, Aris Anagnostopoulos, Stefano Leonardi, Sebastiano Filetti, Cosimo Durante
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism.
ContextThe risk stratification of patients with differentiated thyroid cancer (DTC) is crucial in clinical decision making. The most widely accepted method to assess risk of recurrent/persistent disease is described in the 2015 American Thyroid Assoc